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HUMAN  T  LYMPHOCYTE  "E"  ROSETTE  FUNCTION 
I.  A.  Process Modulated  by Intracellular Cyclic AMP* 
By FRANCIS V.  CHISARI AND THOMAS S.  EDGINGTON 
(From the Department o/Molecular Immunology, Scripps Clinic and Research Foundation, La Jolla, 
California 92037) 
The adenyl cyclase-cyclic 3',5' adenosine monophosphate (cyclic AMP) system is capable 
of  modulating  various  aspects  of  humoral  and  cellular  immune  responses  such  as 
antigen-induced  IgE-mediated  basophil  histamine  release  (1),  lymphocyte-mediated 
cytolysis (2),  complement-mediated cytolysis (3),  and hemolytic plaque formation (4,  5) 
to mention only a  few. 
Sheep red blood cell ("E") rosette formation  has  been  demonstrated to be a  specific 
capacity of human T  lymphocytes (6). This function is depressed in a number of disease 
states  (7-10).  It  is  dependent  on  the  concentration  of divalent cations  (6)  and  can  be 
inhibited by pretreat ment of the lymphocytes with iodoacetate (6), trypsin (6), azide (11), 
antilymphocyte serum  (11),  and cytochalasin B  (12). 
In  the  present  study  we  evaluated  the  effect of various  pharmacologic  agents 
which elevate intracellular cyclic AMP  levels on human  T  lymphocyte E  rosette 
function.  The investigation of this system revealed that the receptor function of 
human  T  lymphocytes necessary to form rosettes with sheep red blood cells can 
be diminished  by such  agents. 
Materials  and Methods 
Reagents.  Cholera toxin was prepared by Dr. R. A. Finkelstein (University of Texas Southwest- 
ern Medical School)  and was provided by Dr.  Carl Miller, NIH. Isoproterenol,  aminophilline, and 
dibutyryl cyclic AMP were purchased from Sigma Chemical Company, St. Louis,  Mo. 
Lymphocyte Culture.  Peripheral blood lymphocytes were isolated from heparinized venous blood 
from normal adults by iron-dextran (Lymphocyte Separating Reagent, Technicon Instruments Corp., 
Tarrytown,  N.  Y.)  sedimentation in  a  magnetic field followed by lysis of erythrocytes with 0.83% 
NH,C1.  The  leukocyte  suspension  was  washed  three  times  with  RPMl-1640.  Absolute  yield of 
lymphocytes was greater than 75% with 99-100% viability (trypan blue) and greater than 90% purity. 
Lymphocytes (1.0 ×  10*/ml) were suspended in 2-ml aliquots in 20% fetal calf serum, RPMI-1640 
supplemented  with  penicillin  (100 U/ml),  streptomycin  (50  mg/ml)  and  L-glutamine  (2  raM) 
containing various concentrations of the pharmacologic  agents under study and incubated at 37°C in 
a  humid atmosphere  containing 5%  CO~ in  air.  The pH was maintained at 7.25-7.35  throughout. 
Experiments were performed in triplicate. 
E  Rosette Assay.  After incubation with pharmacologic  agents,  cells were washed  three times in 
Puck's saline G and adjusted to a concentration of 1 x  106 viable cells per ml (viability remained 
greater than 95% for all conditions and yield of cells at 48 h was 75-80%). 
The assay was performed exactly as described by Jondal, Holm, and Wigzell (9). 400 lymphocytes 
were counted from each of the triplicate determinations. Lymphocytes were scored as positive if four 
or  more  SRBC were  adherent  and  there  was  definite scalloping of the  lymphocyte surface.  The 
arithmetic mean and one standard deviation were calculated. Standard deviation was less than ±5%. 
Results were expressed  as percent inhibition relative to the percent E rosettes  formed by the same 
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lymphocytes cultured simultaneously under control condition (60-75% of total lymphocytes present). 
Utilizing the  E  rosette  technique  in  the  study  of  52  normal  donors  the  percentage  of total 
lymphocytes  which  form  E  rosettes  (72.0%  ±  7.5)  agreed  within  1.6%  with  the  percentage  of 
lymphocytes  lacking  surface  immunoglobulin  (70.4%  :e  5.4).  Surface  immunoglobulin  positive 
lymphocytes were determined by membrane immunofluorescence following staining of viable cells for 
30 min. at 0°C with fluorescein-conjugated IgG fraction of a  polyvalent antisera to IgG, IgA, IgM, 
IgD, kappa, and lambda prepared in a single goat. The fluorescein reagent was rendered monomeric 
by G-200  chromatography and was  titrated  to give a  constant percentage of positive cells over a 
threefold reagent concentration as described by Pernis (13). 
Results 
Time-Course  of  Inhibition  o[  E  Rosette  Function.  The  results  of  four 
representative experiments in which E rosette function was observed to decrease 
following  incubation  of  lymphocytes with  various  pharmacologic  agents  are 
summarized  in  Fig.  1.  The  temporal  features  of  E  rosette  inhibition  were 
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Time-course of inhibitory effect of pharmacologic inhibitors of E  rosette function. 
characteristic  and  reproducible  for  each  agent;  but  the  absolute  degree  of 
inhibition observed with a  given agent varied between donors and from day to 
day. Greater than 80% inhibition was never observed. None of the agents exerted 
a detectable effect on E rosette function within 10 min of incubation. Aminophyl- 
line and isoproterenol were decidedly inhibitory at 1 h; whereas cholera toxin and 
dibutyryl cyclic AMP  had  no  effect at  this  time  but  displayed the  onset  of 
inhibitory activity (not shown) after 2 h  in culture. Cholera toxin reproducibly 
exerted its  maximal effect at 48  h  whereas the other agents induced maximal 
inhibition,  at  24  h,  The  relatively  sustained  inhibitory  effect  of  exogenous 
dibutyryl cyclic AMP contrasts with the transient inhibitory effects of the other 
agents. 
Dose-Response Relationships.  In every experiment the degree of inhibition of 
E. rosette function was directly related to the dose of the agent employed. Table I 
summarizes the data from a  representative experiment. Cholera toxin was the 
most  potent  inhibitor  of  the  group  by  at  least  five  orders  of  magnitude. 
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TABLE I 
Effect of Pharmacologic Inhibitors on E Rosette Formation as a 
Function of Dose 
Concen- 
Agent  tration  E rosettes  Inhibition* 
Cholera toxins 
DiButyryl-cyclic  AMP § 
Isoproterenol § 
Aminophylline§ 
M  %  % 
10  -1~  71.5 ~  4.5  2 
10-~0  54.0 ± 3.6  26 
10 -9  37.5 ± 2.5  49 
10 -8  40.7 ±  1.7  44 
10  ~  69.3 ±  1.7  0 
10  5  70.3 ±  2.5  0 
10  4  54.5 ± 2.7  22 
10 -s  42.0 ± 3.0  40 
10 -~  69.0 ± 3.0  0 
10 -~  62.8 ± 2.8  10 
10  4  50.3 ±  2.3  37 
10 -3  21.5 ±  2.5  68 
10  ~  70.0 ± 4.0  0 
10  ~  71.8 ± 5.0  0 
10  4  53.8 ± 4.8  19 
10 -s  40.3 ± 4.7  42 
* % Inhibition: 100 -  % E reagent/% E control. 
$ Assayed after 48 h in culture. Control  = 73.3% ± "1.7. 
§ Assayed after 24 h in culture. Control  = 69.3% ± 4.8. 
indicated in Table I.  Higher concentrations could not be  evaluated because of 
reduced lymphocyte viability (~90%). 
Potentiating Effect of Aminophylline.  The potentiation of" an agent (cholera 
toxin, isoproterenol) by the phosphodiesterase inhibitor aminophylline has been 
accepted as good presumptive evidence that the agent acts by stimulating adenyl 
cyclase and also that the effect is mediated via the cyclic AMP system (14). We 
therefore cultivated lymphocytes in media containing both a  noninhibiting dose 
of aminophylline and a  suboptimal dose of each agent. A pronounced synergistic 
effect was obtained when these agents were administered simultaneously (Table 
II). 
Discussion 
The inhibition of E  rosette function by the adenyl cyclase stimulators, cholera 
toxin  and  isoproterenol,  and  the  phosphodiesterase  inhibitor,  aminophylline, 
suggests that  cyclic AMP  may participate in the regulation of this lymphocyte 
membrane  function. This  hypothesis  is  strengthened  by  the  observation that 
exogenous  dibutyryl cyclic AMP  exerts  a  sustained inhibiting influence on  E 
rosette  formation.  Finally,  the  potentiating  effect  of  the  phosphodiesterase 
inhibitor in the  presence  of either the  adenyl cyclase stimulators or  dibutyryl 
cyclic AMP  further supports this interpretation. 
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TABLE II 




Agent  tration  E rosettes  Inhibitions 
M  %  % 
Aminophylline  10  -e  68.0 ± 1.0  0 
Isoproterenol  10- *  53.3 ± 5.0  20 
"  + Aminophylline  10  .6  41.3 ± 4.7  40 
Cholera toxin  10-10  53.0 ± 2.0  22 
" + Aminophylline  10-6  47.5 ± 1.5  34 
Dibutyrl cyclic AMP  10-*  55.8 ± 4.2  18 
"  ÷ Aminophylline  10 -8  43.8 ± 3.8  35 
* All conditions assayed after 24 h in culture.  Control  = 67.8 ± 3.8 
$ % Inhibition:  100 -  % E reagent/% E control. 
keeping  with  the  rate  at  which  each  agent  induces  measurable  changes  in 
intracellular  cyclic AMP  (15,  16).  The  relatively sustained  inhibitory  effect of 
exogenous dibutyryl cyclic AMP at 48 and 72 h  suggests that E  rosette function 
may be susceptible to  inhibition  for as  long as  intracellular  cyclic AMP  levels 
remain  elevated. Likewise, the transient  inhibitory effect of the other agents is 
consistent with  the  transient  elevations of intracellular cyclic AMP which they 
evoke (15,  16). 
Since there is a significant delay between the time when cyclic AMP levels rise 
(15,  16) and E  rosette function falls, it is likely that diminished E  rosette function 
is a secondary or tertiary event mediated by changes in intracellular cyclic AMP. 
Increased intracellular  cyclic AMP may decrease synthesis of a  discrete receptor 
for sheep  erythrocytes,  decrease  incorporation  of this  receptor into the  plasma 
membrane,  or  lead  to  increased  shedding  of  receptor  from  the  lymphocyte 
surface.  Precise  evaluation  of these  hypotheses  must  await  the  isolation  and 
purification of this  putative receptor. 
Summary 
The  capacity  of normal  human  T  lymphocytes to form rosettes with  sheep red 
blood  cells  can  be  inhibited  by  drugs  or  agents  which  induce  elevations  in 
intracellular  levels of cyclic A VIP.  The effect is early in the  presence of agents 
which  elicit  rapid  elevations in  intracellular  cyclic AMP  (isoproterenol,  amino- 
phylline) and occurs later in the presence of cholera toxin which induces a dalayed 
increase in endogenous cyclic AMP. Dibutyryl cyclic AMP is inhibitory, and the 
effects of dibutyryl  cyclic  AMP  and  the  adenyl  cyclase stimulators  are  poten- 
tiated  by  inhibition  of  phosphodiesterase.  These  data  provide  substantial 
evidence that elevation of intracellular cyclic AMP diminishes E  rosette function 
of lymphocytes. 
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